Journal of Attention Disorders
As research in the field of attention grows, so does your need to keep up with the latest developments. What better source than Journal of Attention Disorders, the only journal devoted exclusively to research and clinical issues related to attention?
Journal of Attention Disorders provides an objective and widely diverse cross section of studies written by leaders in the field of attention. Included are articles on
- Diagnosis
- Comorbidity
- Neuropsychological functioning
- Psychopharmacology
- Classroom management strategies
- Parent training
- Behavioral assessment
- Diet
- Family therapy
- And other areas relevant to attention problems in children, adolescents, and youth
This journal is a member of the Committee on Publication Ethics (COPE).
Focuses on basic and applied research and clinical issues related to attention in children, adolescents, and adults. Included are articles on diagnosis, comorbidity, neuropsychological functioning, psychopharamacology, and classroom management strategies.
Michael Kofler | Florida State University, USA |
Jennifer Bolden | University of Tennessee-Knoxville, USA |
Anil Chacko | New York University, USA |
Tycho Dekkers | University of Groningen, the Netherlands |
Melissa Dvorsky | Children’s National Research Institute, USA |
Cynthia M. Hartung | University of Wyoming, USA |
Amori Mikami | University of British Columbia, Canada |
Erica Musser | Florida International University, USA |
Jeffrey H. Newcorn | Mount Sinai School of Medicine, New York, USA |
Molly Nikolas | University of Iowa, USA |
Keri Shiels Rosch | Kennedy Krieger Institute, USA |
Margaret Sibley | Seattle Children’s Hospital, USA |
Keith Conners | Duke University, USA |
Sam Goldstein PhD | Neurology Learning & Behavior Center, USA |
Ann Abramowitz | Emory University, USA |
Carla Allan | University of Missouri-Kansas City, School of Medicine, USA |
Kevin M. Antshel, Ph.D. | SUNY-Upstate Medical University, USA |
Anne Arnett | Boston Children's Hospital Division of Developmental Medicine, USA |
Lindsay Ayearst | Multi Health Systems Inc., Canada |
Raman Baweja | Penn State Health, USA |
Stephen P. Becker, MA | Cincinnati Children's Hospital Medical Center, USA |
Jake Behrens | ADHD Clinic, Milwaukee, WI, USA |
Eva Billstedt | University of Gothenburg, Sweden |
Rosanna Breaux | Virginia Tech, USA |
Ronald T. Brown | University of Nevada, Las Vegas, USA |
Thomas E. Brown | Yale University, School of Medicine, USA |
Betsy Busch | Tufts University School of Medicine, USA |
Will Canu | Appalachian State University, USA |
Ann Childress | Center for Psychiatry and Behavioral Medicine, Inc., USA |
Andrea Chronis-Tuscano | University of Maryland, USA |
David Coghill | University of Dundee, Ireland |
Mara Cordeiro | UC Davis Medical Center, USA |
Robert Doyle | Harvard University, USA |
George DuPaul | Lehigh University, USA |
William O. Dwyer | The University of Memphis, USA |
Ricardo Eiraldi | Neurology Learning & Behavior Center, USA |
Glen Elliott | Children's Health Council, USA |
Jeff Epstein | University of Cincinnati College of Medicine, USA |
Kate Flory | University of South Carolina, USA |
Lauren M. Friedman | Arizona State University, USA |
Patrick Goh | University of Hawai'i at Manoa, USA |
Sam Goldstein PhD | Neurology Learning & Behavior Center, USA |
Rapson Gomez | Federation University Australia, Australia |
David W. Goodman | University of Sydney, Australia |
Matthew J. Gormley | University of Nebraska-Lincoln, USA |
Thomas Gualtieri | NC Neuropsychiatry, USA |
Lily Hechtman | McGill University Health Centre, Canada |
John Heiligenstein | Eli Lilly and Company, USA |
Jonathan L. Hess | SUNY Upstate Medical University, USA |
Benjamin D. Hill | University of South Alabama, USA |
Stephen Hinshaw | UC Berkeley, USA |
Betsy Hoza | University of Vermont, USA |
Peter Jensen | The REACH Institue, USA |
Heather Jones | Virginia Tech University, USA |
Ridha Joober | Douglas Hospital Research Centre, Canada |
Gagan Joshi | Harvard Medical School, Boston, MA, USA |
Jeffrey S. Katz | Katz Group for Psychological Services, USA |
Martin A. Katzman | START Clinic for Mood and Anxiety Disorders, Canada |
Rachel Klein | New York University School of Medicine, USA |
Scott Kollins | Duke University, USA |
Beth Krone | Ichan School of Medicine at Mount Sinai, NY, USA |
William G. Kronenberger | Indiana University School of Medicine, USA |
Florence Levy | University of New South Wales, Australia |
Sandra Loo | UCLA Neuropsychiatric Research Institute, USA |
Benjamin J. Lovett, Ph.D. | Columbia University, USA |
Iris Manor, M.D | Tel Aviv University, Israel |
Greg Mattingly | Washington University School of Medicine, USA |
Paulo Mattos | |
Keith McBurnett | University of California, San Francisco, USA |
Michael Meinzer | University of Illinois at Chicago, USA |
Eric Mick | Harvard University, USA |
Brooke S. G. Molina | University of Pittsburgh School of Medicine, USA |
Guillermo Montes | St. John Fisher College, USA |
Kevin Murphy | |
Jeffrey H. Newcorn | Mount Sinai School of Medicine, New York, USA |
Jill M. Norvilitis | Buffalo State College, USA |
Anne O'Hare | University of Edinburgh, UK |
James D. A. Parker | Trent University, Canada |
William E. Pelham | Florida International University, USA |
Linda Pfiffner | UC San Fransisco, USA |
Steve R. Pliszka | University of Texas in San Antonio, USA |
Yehuda Pollak | The Hebrew University of Jerusalem, Israel |
David L. Rabiner | Duke University, USA |
Joseph Raiker | Florida International University, USA |
Russell Ramsay | University of Pennsylvania, USA |
Frederick Reimherr | |
Cecil Reynolds | Texas A&M University, USA |
Luis A. Rohde | UFRGS Psychiatry, Brazil |
Tony Rostain | University of Pennsylvania, USA |
Julia Rucklidge | University of Canterbury, New Zealand |
Steven Safren | University of Miami, USA |
Dustin Sarver | University of Mississippi Medical Center, USA |
Julie Schweitzer | University of California Davis School of Medicine, USA |
Larry J Seidman | Harvard University, USA |
Salih Selek | University of Texas, Health Science Center at Houston, USA |
Bengi Semeci | |
Margaret Semrud-Clikeman | University of Minnesota, USA |
Karen E. Seymour | Johns Hopkins University School of Medicine, USA |
Nitzan Shahar | Tel-Aviv University, Israel |
Elizabeth Short | Case Western Reserve University, USA |
Mary V. Solanto | Hofstra University, USA |
Elizabeth Sparrow | Sparrow Neuropsychology, USA |
Thomas Spencer | Massachusettes General Hospital, USA |
Mark Stein | University of Washington, USA |
Gary Stoner | University of Massachusetts, USA |
Craig Surman, M.D. | Massachusetts General Hospital, USA |
Ali Talaei | Mashhad University of Medical Sciences, Iran |
David Teplin | Private Practice, Toronto, Canada |
Mai Uchida | Harvard Medical School, Boston, Massachusetts, USA |
Robert Volpe | Northeastern University, USA |
Roberta Waite | Drexal University College of Nursing and Health Professions, USA |
Jeanette Wasserstein | Board Certified in Clinical Neuropsychology |
James Waxmonsky | Penn State Health, USA |
Margaret Weiss | University of British Columbia, Canada |
Lisa Weyandt | University of Rhode Island, USA |
Carol K. Whalen | UC Irvine, USA |
Sharon B. Wigal | UC Irvine, USA |
Timothy Wigal | UC Irvine, USA |
Timothy Wilens | Harvard Medical School, USA |
Mark Wolraich | University of Oklahoma Health Sciences Center Pediatrics, USA |
Janet Wozniak | Harvard Medical School, USA |
Fran Wymbs | Ohio University, USA |
Susan Young | Institute of Psychiatry, London, UK |
Francisco Xavier Castellanos | New York University School of Medicine, USA |
Steven W. Evans | Ohio University, USA |
Natalie Grizenko | Douglas Institute, Canada |
Jeffrey M. Halperin | CUNY, USA |
Stephen P. Hinshaw | UC Berkeley, USA |
Joshua M. Langberg | Rutgers University, USA |
Joel Nigg | Oregon Health & Science University, USA |
Rick Ostrander | Johns Hopkins University Medical Institutions, USA |
Robert Resnick | Randolph-Macon College, USA |
Cynthia Riccio | Texas A&M University, USA |
Arthur Robin | Wayne State University School of Medicine, USA |
Hans-Christoph Steinhausen | Psychiatric University Clinic Zurich, Switzerland |
*** Please note: the Journal is transitioning to a new Editor and Associate Editor team in 2024. There may be delays in manuscript flow/decisions during this transition. Your patience is appreciated! ***
Journal of Attention Disorders (JAD) focuses on basic and applied science concerning attention and related functions in children, adolescents, and adults. JAD publishes articles including, but not limited to, diagnosis, comorbidity, neuropsychological functioning, psychopharmacology, and psychosocial issues. The journal welcomes manuscripts addressing timely, notable topics in practice, policy, and theory, as well as review articles, commentaries, in-depth analyses, empirical research articles, and case presentations or program evaluations that illustrate theoretical issues or new phenomena.
Submission
*New in 2024*
In an effort to reduce barriers to publication, JAD is moving to a “format-free” submission policy beginning in 2024. This means that there are no specific formatting requirements at the peer review stage. However, all manuscripts still need to contain the critical information needed to evaluate them, including an Abstract, a main text that includes sufficient detail to allow critical evaluation of the paper’s unique contribution and methodological rigor (for regular articles, this will typically include Introduction, Method, Results, Discussion, and Limitations/future Directions sections). There are no strict page lengths. Manuscripts should be succinct while providing sufficient detail to allow others to replicate the work (and to facilitate peer review).
Information on funding source(s), a reference section, author affiliations, and details regarding any actual or potential conflicts of interest are also necessary. If there are no potential conflicts of interest, please state this explicitly.
Authors will also be asked to supply 3-5 keywords/key phrases. Keywords should reflect the main topics of your research. Where more than one phrase (or abbreviation) is often used to describe the same thing, include both/all variants, e.g., drug names. Guidance on keyword section and optimizing your manuscript to help readers find your study can be found here: [link].
Additional information will be required for accepted papers, including author bios and ORCIDs. Tables and figures can be included in the main document or uploaded as separate documents. Figures should be of sufficient quality/resolution to allow peer review. Cover letters are optional.
A title page should be provided as a separate document. The manuscript should be formatted for masked/anonymous review.
References can be in any style, as long as a consistent format is applied (e.g., APA, AJP, AMA) and the necessary information is provided (e.g., author names, journal/book title, article/chapter title, publication year, page numbers). All articles cited in text must be included in the Reference section and vice versa. DOIs (Digital Object Identifiers) are recommended but not required.
The journal’s reference style will be applied to accepted papers during post-production by Sage.
Spelling can be UK or US English so long as it is consistent throughout the manuscript.
An editable version of the article must be supplied at the revision stage. For accepted articles, any Figures or Artwork should have a resolution of 300 dpi or higher and be uploaded as files separate from the main manuscript.
Submission to the journal implies that the manuscript has not been published elsewhere and is not in consideration by any other journal.
Journal of Attention Disorders only accepts submissions electronically. Electronic submissions should be sent to http://mc.manuscriptcentral.com/jad.
Best Student Paper Awards
*New in 2024*
We are excited to announce a new initiative to recognize up-and-coming researchers! The JAD submission portal now includes an option to indicate that the lead author of a submission is a student (or was a student when the work was completed). Exceptional student submissions will receive the distinction of Best Student Paper Award and receive a $500 honorarium. We plan to make 1-2 awards per year.
Orcid
As part of our commitment to ensuring an ethical, transparent, and fair peer review process Sage is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a unique and persistent digital identifier that distinguishes researchers from every other researcher, even those who share the same name, and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities, ensuring that their work is recognized.
The collection of ORCID iDs from corresponding authors is now part of the submission process of this journal. If you already have an ORCID iD you will be asked to associate that to your submission during the online submission process. We also strongly encourage all co-authors to link their ORCID ID to their accounts in our online peer review platforms. It takes seconds to do: click the link when prompted, sign into your ORCID account, and our systems are automatically updated. Your ORCID iD will become part of your accepted publication’s metadata, making your work attributable to you and only you. Your ORCID iD is published with your article so that fellow researchers reading your work can link to your ORCID profile and from there link to your other publications.
If you do not already have an ORCID iD please follow this link to create one or visit our ORCID homepage to learn more.
Featured Sections
JAD features applied research. JAD additionally publishes unsolicited articles in three other sections: Research Into Practice, Research Briefs, and Literature Reviews. The first, Research Into Practice, should focus on well-developed areas of research with an emphasis on application and evaluation of practice. Specifically, the goal of these submissions is to illustrate how relevant conceptual and empirical principles can be implemented in evaluating and practice. Manuscripts should present theoretically sound and empirically documented principles and illustrate how these have been synthesized into practiced and proven interventions.
The journal is also interested in publishing articles in a Research Briefs section promoting the dissemination of new, novel, or otherwise important research information in a format that does not require extensive journal space. Research briefs should be substantially shorter than general articles. Although there are no strict page limits, research briefs should generally be no longer than 15 pages, including tables, figures, and references. When submitting a manuscript for consideration as a research brief, the author should so stipulate and agree not to publish a more comprehensive version of the article in another source.
Finally, the journal is interested in publishing systematic literature reviews and meta-analyses. Authors considering conducting a systematic review/meta-analysis should consider contacting the Editor before submission. JAD will also publish relevant letters describing interesting cases of developments in the field relative to clinical practice.
The journal also welcomes Letters to the Editor of no more than 300 words. Letters will be published at the editor’s discretion. Opinion essays on relevant topics in ADHD are published by invitation only.
Authors who want to refine the use of English in their manuscripts might consider utilizing the services of SPi, a non-affiliated company that offers Professional Editing Services to authors of journal articles in the areas of science, technology, medicine, or the social sciences. SPi specializes in editing and correcting English-language manuscripts written by authors with a primary language other than English. Visit http://www.prof-editing.com for more information about SPi’s Professional Editing Services, pricing, and turn-around times, or to obtain a free quote or submit a manuscript for language polishing.
Please be aware that Sage has no affiliation with SPi and makes no endorsement of the company. An author’s use of SPi’s services in no way guarantees that his or her submission will ultimately be accepted. Any arrangement an author enters into will be exclusively between the author and SPi, and any costs incurred are the sole responsibility of the author.
This journal is a member of the Committee on Publication Ethics (COPE).
If you or your funder wish your article to be freely available online to nonsubscribers immediately upon publication (gold open access), you can opt for it to be included in Sage Choice, subject to the payment of a publication fee. The manuscript submission and peer review procedure is unchanged. On acceptance of your article, you will be asked to let Sage know directly if you are choosing Sage Choice. To check journal eligibility and the publication fee, please visit Sage Choice. For more information on open access options and compliance at Sage, including self/author archiving deposits (green open access) visit Sage Publishing Policies on our Journal Author Gateway.